Targeting leukocyte traffic: A new era for the treatment of Inflammatory bowel disease-Reference-Cited by-同舟云学术

Targeting leukocyte traffic: A new era for the treatment of Inflammatory bowel disease

Published:2018-08 Issue:suppl_2 Volume:12 Page:S631-S632
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Rivera-Nieves Jesus¹

Affiliation:

1. University of California at San Diego, Inflammatory Bowel Disease Center, Division of Gastroenterology, San Diego, CA, USA

Funder

National Institutes of Health

F. Hoffmann-La Roche Ltd

Takeda Development Center Americas, Inc

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/12/suppl_2/S631/25526346/jjy067.pdf

Reference14 articles.

1. Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ-specific determinants on high endothelial venules;Butcher;Eur J Immunol,1980

2. Tumour-necrosis-factor antibody treatment in Crohn’s disease;Derkx;Lancet,1993

3. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn’s disease. Crohn’s Disease cA2 Study Group;Targan;N Engl J Med,1997

4. The recirculation of lymphocytes from blood to lymph in the rat;Gowans;J Physiol,1959

5. Lymphocytes, Jim Gowans and in vivo veritas;Weissman;Nat Immunol,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn’s-Like Ileitis by Suppressing Thymocyte Maturation;Inflammatory Bowel Diseases;2019-12-06